1 Hepatitis A Vaccine Market Overview 1.1 Product Overview and Scope of Hepatitis A Vaccine 1.2 Hepatitis A Vaccine Segment by Type 1.2.1 Global Hepatitis A Vaccine Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Inactivated Vaccine 1.2.3 Live Attenuated Vaccine 1.3 Hepatitis A Vaccine Segment by Application 1.3.1 Hepatitis A Vaccine Sales Comparison by Application: (2021-2027) 1.3.2 Government Institution 1.3.3 Private Sector 1.3.4 Other 1.4 Global Hepatitis A Vaccine Market Size Estimates and Forecasts 1.4.1 Global Hepatitis A Vaccine Revenue 2016-2027 1.4.2 Global Hepatitis A Vaccine Sales 2016-2027 1.4.3 Hepatitis A Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027 2 Hepatitis A Vaccine Market Competition by Manufacturers 2.1 Global Hepatitis A Vaccine Sales Market Share by Manufacturers (2016-2021) 2.2 Global Hepatitis A Vaccine Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Hepatitis A Vaccine Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Hepatitis A Vaccine Manufacturing Sites, Area Served, Product Type 2.5 Hepatitis A Vaccine Market Competitive Situation and Trends 2.5.1 Hepatitis A Vaccine Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Hepatitis A Vaccine Players Market Share by Revenue 2.5.3 Global Hepatitis A Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Hepatitis A Vaccine Retrospective Market Scenario by Region 3.1 Global Hepatitis A Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021 3.2 Global Hepatitis A Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021 3.3 North America Hepatitis A Vaccine Market Facts & Figures by Country 3.3.1 North America Hepatitis A Vaccine Sales by Country 3.3.2 North America Hepatitis A Vaccine Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Hepatitis A Vaccine Market Facts & Figures by Country 3.4.1 Europe Hepatitis A Vaccine Sales by Country 3.4.2 Europe Hepatitis A Vaccine Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Hepatitis A Vaccine Market Facts & Figures by Region 3.5.1 Asia Pacific Hepatitis A Vaccine Sales by Region 3.5.2 Asia Pacific Hepatitis A Vaccine Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Hepatitis A Vaccine Market Facts & Figures by Country 3.6.1 Latin America Hepatitis A Vaccine Sales by Country 3.6.2 Latin America Hepatitis A Vaccine Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Hepatitis A Vaccine Market Facts & Figures by Country 3.7.1 Middle East and Africa Hepatitis A Vaccine Sales by Country 3.7.2 Middle East and Africa Hepatitis A Vaccine Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Hepatitis A Vaccine Historic Market Analysis by Type 4.1 Global Hepatitis A Vaccine Sales Market Share by Type (2016-2021) 4.2 Global Hepatitis A Vaccine Revenue Market Share by Type (2016-2021) 4.3 Global Hepatitis A Vaccine Price by Type (2016-2021) 5 Global Hepatitis A Vaccine Historic Market Analysis by Application 5.1 Global Hepatitis A Vaccine Sales Market Share by Application (2016-2021) 5.2 Global Hepatitis A Vaccine Revenue Market Share by Application (2016-2021) 5.3 Global Hepatitis A Vaccine Price by Application (2016-2021) 6 Key Companies Profiled 6.1 GSK 6.1.1 GSK Corporation Information 6.1.2 GSK Description and Business Overview 6.1.3 GSK Hepatitis A Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.1.4 GSK Product Portfolio 6.1.5 GSK Recent Developments/Updates 6.2 Merck 6.2.1 Merck Corporation Information 6.2.2 Merck Description and Business Overview 6.2.3 Merck Hepatitis A Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Merck Product Portfolio 6.2.5 Merck Recent Developments/Updates 6.3 Sanofi 6.3.1 Sanofi Corporation Information 6.3.2 Sanofi Description and Business Overview 6.3.3 Sanofi Hepatitis A Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Sanofi Product Portfolio 6.3.5 Sanofi Recent Developments/Updates 6.4 Sinovac 6.4.1 Sinovac Corporation Information 6.4.2 Sinovac Description and Business Overview 6.4.3 Sinovac Hepatitis A Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Sinovac Product Portfolio 6.4.5 Sinovac Recent Developments/Updates 6.5 Zhejiang Pukang 6.5.1 Zhejiang Pukang Corporation Information 6.5.2 Zhejiang Pukang Description and Business Overview 6.5.3 Zhejiang Pukang Hepatitis A Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Zhejiang Pukang Product Portfolio 6.5.5 Zhejiang Pukang Recent Developments/Updates 6.6 Changchun Institute of Biological 6.6.1 Changchun Institute of Biological Corporation Information 6.6.2 Changchun Institute of Biological Description and Business Overview 6.6.3 Changchun Institute of Biological Hepatitis A Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Changchun Institute of Biological Product Portfolio 6.6.5 Changchun Institute of Biological Recent Developments/Updates 6.7 KM Biologics 6.6.1 KM Biologics Corporation Information 6.6.2 KM Biologics Description and Business Overview 6.6.3 KM Biologics Hepatitis A Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.4.4 KM Biologics Product Portfolio 6.7.5 KM Biologics Recent Developments/Updates 6.8 IMBCA 6.8.1 IMBCA Corporation Information 6.8.2 IMBCA Description and Business Overview 6.8.3 IMBCA Hepatitis A Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.8.4 IMBCA Product Portfolio 6.8.5 IMBCA Recent Developments/Updates 6.9 ChangSheng 6.9.1 ChangSheng Corporation Information 6.9.2 ChangSheng Description and Business Overview 6.9.3 ChangSheng Hepatitis A Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.9.4 ChangSheng Product Portfolio 6.9.5 ChangSheng Recent Developments/Updates 6.10 Convac 6.10.1 Convac Corporation Information 6.10.2 Convac Description and Business Overview 6.10.3 Convac Hepatitis A Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Convac Product Portfolio 6.10.5 Convac Recent Developments/Updates 7 Hepatitis A Vaccine Manufacturing Cost Analysis 7.1 Hepatitis A Vaccine Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Hepatitis A Vaccine 7.4 Hepatitis A Vaccine Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Hepatitis A Vaccine Distributors List 8.3 Hepatitis A Vaccine Customers 9 Hepatitis A Vaccine Market Dynamics 9.1 Hepatitis A Vaccine Industry Trends 9.2 Hepatitis A Vaccine Growth Drivers 9.3 Hepatitis A Vaccine Market Challenges 9.4 Hepatitis A Vaccine Market Restraints 10 Global Market Forecast 10.1 Hepatitis A Vaccine Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Hepatitis A Vaccine by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Hepatitis A Vaccine by Type (2022-2027) 10.2 Hepatitis A Vaccine Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Hepatitis A Vaccine by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Hepatitis A Vaccine by Application (2022-2027) 10.3 Hepatitis A Vaccine Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Hepatitis A Vaccine by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Hepatitis A Vaccine by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Hepatitis A Vaccine Sales (K MT) Growth Rate Comparison by Type (2021-2027) Table 2. Global Hepatitis A Vaccine Sales (K MT) Comparison by Application (2021-2027) Table 3. Global Hepatitis A Vaccine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Hepatitis A Vaccine Covered in This Study Table 5. Global Hepatitis A Vaccine Sales (K MT) of Key Manufacturers (2016-2021) Table 6. Global Hepatitis A Vaccine Sales Share by Manufacturers (2016-2021) Table 7. Global Hepatitis A Vaccine Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Hepatitis A Vaccine Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Hepatitis A Vaccine Average Price (USD/MT) of Key Manufacturers (2016-2021) Table 10. Manufacturers Hepatitis A Vaccine Manufacturing Sites and Area Served Table 11. Manufacturers Hepatitis A Vaccine Product Type Table 12. Global Hepatitis A Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Hepatitis A Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis A Vaccine as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Hepatitis A Vaccine Sales by Region (2016-2021) & (K MT) Table 16. Global Hepatitis A Vaccine Sales Market Share by Region (2016-2021) Table 17. Global Hepatitis A Vaccine Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Hepatitis A Vaccine Sales by Country (2016-2021) & (K MT) Table 19. North America Hepatitis A Vaccine Sales Market Share by Country (2016-2021) Table 20. North America Hepatitis A Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Hepatitis A Vaccine Revenue Market Share by Country (2016-2021) Table 22. Europe Hepatitis A Vaccine Sales by Country (2016-2021) & (K MT) Table 23. Europe Hepatitis A Vaccine Sales Market Share by Country (2016-2021) Table 24. Europe Hepatitis A Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Hepatitis A Vaccine Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Hepatitis A Vaccine Sales by Region (2016-2021) & (K MT) Table 27. Asia Pacific Hepatitis A Vaccine Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Hepatitis A Vaccine Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Hepatitis A Vaccine Revenue Market Share by Region (2016-2021) Table 30. Latin America Hepatitis A Vaccine Sales by Country (2016-2021) & (K MT) Table 31. Latin America Hepatitis A Vaccine Sales Market Share by Country (2016-2021) Table 32. Latin America Hepatitis A Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Hepatitis A Vaccine Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Hepatitis A Vaccine Sales by Country (2016-2021) & (K MT) Table 35. Middle East and Africa Hepatitis A Vaccine Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Hepatitis A Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Hepatitis A Vaccine Revenue Market Share by Country (2016-2021) Table 38. Global Hepatitis A Vaccine Sales (K MT) by Type (2016-2021) Table 39. Global Hepatitis A Vaccine Sales Market Share by Type (2016-2021) Table 40. Global Hepatitis A Vaccine Revenue (Million US$) by Type (2016-2021) Table 41. Global Hepatitis A Vaccine Revenue Share by Type (2016-2021) Table 42. Global Hepatitis A Vaccine Price (USD/MT) by Type (2016-2021) Table 43. Global Hepatitis A Vaccine Sales (K MT) by Application (2016-2021) Table 44. Global Hepatitis A Vaccine Sales Market Share by Application (2016-2021) Table 45. Global Hepatitis A Vaccine Revenue (Million US$) by Application (2016-2021) Table 46. Global Hepatitis A Vaccine Revenue Share by Application (2016-2021) Table 47. Global Hepatitis A Vaccine Price (USD/MT) by Application (2016-2021) Table 48. GSK Corporation Information Table 49. GSK Description and Business Overview Table 50. GSK Hepatitis A Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 51. GSK Hepatitis A Vaccine Product Table 52. GSK Recent Developments/Updates Table 53. Merck Corporation Information Table 54. Merck Description and Business Overview Table 55. Merck Hepatitis A Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 56. Merck Hepatitis A Vaccine Product Table 57. Merck Recent Developments/Updates Table 58. Sanofi Corporation Information Table 59. Sanofi Description and Business Overview Table 60. Sanofi Hepatitis A Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 61. Sanofi Hepatitis A Vaccine Product Table 62. Sanofi Recent Developments/Updates Table 63. Sinovac Corporation Information Table 64. Sinovac Description and Business Overview Table 65. Sinovac Hepatitis A Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 66. Sinovac Hepatitis A Vaccine Product Table 67. Sinovac Recent Developments/Updates Table 68. Zhejiang Pukang Corporation Information Table 69. Zhejiang Pukang Description and Business Overview Table 70. Zhejiang Pukang Hepatitis A Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 71. Zhejiang Pukang Hepatitis A Vaccine Product Table 72. Zhejiang Pukang Recent Developments/Updates Table 73. Changchun Institute of Biological Corporation Information Table 74. Changchun Institute of Biological Description and Business Overview Table 75. Changchun Institute of Biological Hepatitis A Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 76. Changchun Institute of Biological Hepatitis A Vaccine Product Table 77. Changchun Institute of Biological Recent Developments/Updates Table 78. KM Biologics Corporation Information Table 79. KM Biologics Description and Business Overview Table 80. KM Biologics Hepatitis A Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 81. KM Biologics Hepatitis A Vaccine Product Table 82. KM Biologics Recent Developments/Updates Table 83. IMBCA Corporation Information Table 84. IMBCA Description and Business Overview Table 85. IMBCA Hepatitis A Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 86. IMBCA Hepatitis A Vaccine Product Table 87. IMBCA Recent Developments/Updates Table 88. ChangSheng Corporation Information Table 89. ChangSheng Description and Business Overview Table 90. ChangSheng Hepatitis A Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 91. ChangSheng Hepatitis A Vaccine Product Table 92. ChangSheng Recent Developments/Updates Table 93. Convac Corporation Information Table 94. Convac Description and Business Overview Table 95. Convac Hepatitis A Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 96. Convac Hepatitis A Vaccine Product Table 97. Convac Recent Developments/Updates Table 98. Production Base and Market Concentration Rate of Raw Material Table 99. Key Suppliers of Raw Materials Table 100. Hepatitis A Vaccine Distributors List Table 101. Hepatitis A Vaccine Customers List Table 102. Hepatitis A Vaccine Market Trends Table 103. Hepatitis A Vaccine Growth Drivers Table 104. Hepatitis A Vaccine Market Restraints Table 105. Global Hepatitis A Vaccine Sales Forecast by Type (2022-2027) & (K MT) Table 106. Global Hepatitis A Vaccine Sales Market Share Forecast by Type (2022-2027) Table 107. Global Hepatitis A Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million) Table 108. Global Hepatitis A Vaccine Revenue Market Share Forecast by Type (2022-2027) Table 109. Global Hepatitis A Vaccine Sales Forecast by Application (2022-2027) & (K MT) Table 110. Global Hepatitis A Vaccine Sales Market Share Forecast by Application (2022-2027) Table 111. Global Hepatitis A Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million) Table 112. Global Hepatitis A Vaccine Revenue Market Share Forecast by Application (2022-2027) Table 113. Global Hepatitis A Vaccine Sales Forecast by Region (2022-2027) & (K MT) Table 114. Global Hepatitis A Vaccine Sales Market Share Forecast by Region (2022-2027) Table 115. Global Hepatitis A Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million) Table 116. Global Hepatitis A Vaccine Revenue Market Share Forecast by Region (2022-2027) Table 117. Research Programs/Design for This Report Table 118. Key Data Information from Secondary Sources Table 119. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Hepatitis A Vaccine Figure 2. Global Hepatitis A Vaccine Market Share by Type in 2020 & 2027 Figure 3. Inactivated Vaccine Product Picture Figure 4. Live Attenuated Vaccine Product Picture Figure 5. Global Hepatitis A Vaccine Market Share by Application in 2020 & 2027 Figure 6. Government Institution Figure 7. Private Sector Figure 8. Other Figure 9. Global Hepatitis A Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Hepatitis A Vaccine Market Size 2016-2027 (US$ Million) Figure 11. Global Hepatitis A Vaccine Sales 2016-2027 (K MT) Figure 12. Global Hepatitis A Vaccine Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 13. Hepatitis A Vaccine Sales Share by Manufacturers in 2020 Figure 14. Global Hepatitis A Vaccine Revenue Share by Manufacturers in 2020 Figure 15. The Global 5 and 10 Largest Hepatitis A Vaccine Players: Market Share by Revenue in 2020 Figure 16. Hepatitis A Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 17. Global Hepatitis A Vaccine Sales Market Share by Region (2016-2021) Figure 18. Global Hepatitis A Vaccine Sales Market Share by Region in 2020 Figure 19. Global Hepatitis A Vaccine Revenue Market Share by Region (2016-2021) Figure 20. Global Hepatitis A Vaccine Revenue Market Share by Region in 2020 Figure 21. U.S. Hepatitis A Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 22. Canada Hepatitis A Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Germany Hepatitis A Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. France Hepatitis A Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. U.K. Hepatitis A Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Italy Hepatitis A Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Russia Hepatitis A Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. China Hepatitis A Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Japan Hepatitis A Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. South Korea Hepatitis A Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. India Hepatitis A Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Australia Hepatitis A Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Taiwan Hepatitis A Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Indonesia Hepatitis A Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Thailand Hepatitis A Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Malaysia Hepatitis A Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Philippines Hepatitis A Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Vietnam Hepatitis A Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Mexico Hepatitis A Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Brazil Hepatitis A Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Argentina Hepatitis A Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Turkey Hepatitis A Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Saudi Arabia Hepatitis A Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. U.A.E Hepatitis A Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Sales Market Share of Hepatitis A Vaccine by Type (2016-2021) Figure 46. Sales Market Share of Hepatitis A Vaccine by Application (2016-2021) Figure 47. Sales Market Share of Hepatitis A Vaccine by Application in 2020 Figure 48. Revenue Share of Hepatitis A Vaccine by Application (2016-2021) Figure 49. Revenue Share of Hepatitis A Vaccine by Application in 2020 Figure 50. Manufacturing Cost Structure of Hepatitis A Vaccine Figure 51. Manufacturing Process Analysis of Hepatitis A Vaccine Figure 52. Hepatitis A Vaccine Industrial Chain Analysis Figure 53. Channels of Distribution Figure 54. Distributors Profiles Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

GSK Merck Sanofi Sinovac Zhejiang Pukang Changchun Institute of Biological KM Biologics IMBCA ChangSheng Convac